Kevin Chapman
Chief Scientific Officer at Prellis Biologics · Previously invested at Celesta Capital
Investments
1
Lead Investments
1
Highlights
Focus Areas
3D Printing
Biopharma
Biotechnology
Therapeutics
Firms Invested Under
Recent Investments
Chief Scientific Officer at Prellis Biologics · Previously invested at Celesta Capital
Focus Areas
Firms Invested Under
Recent Investments